The disease is usually preceded by a premalignant condition (MBL) which shares most molecular motorists with overt CLL. In lots of circumstances, these molecular drivers remain frequent after some time. Having said that, clonal evolution is usually possible and is often affiliated with exponential tumor growth, progressive ailment and, in some inst